Robert Sedlock, Director of Technical Training at Natoli Engineering, will speak on “Specialized Tableting Techniques to Create a More Patient Friendly Dosage Form” as part of a panel at the 2016 AAPS Annual Meeting and Exposition. This section is one of nine such section in the short course, Innovative Technologies to Facilitate Patient-Friendly Dosage Forms, taking place on November 13th.
Description of the full short course from the AAPS website:
It is projected that the global pharmaceutical industry loses an estimated $564 billion annually to issues with patient compliance. To overcome this loss and improve the outcome for patients, it is vital to develop innovative products that are tailored to specific patient populations and indications. This short course will review the benefits, as well as cover the formulation and process development of patient friendly [sic] dosage forms to assist formulation scientists in their own development efforts.
Mr. Sedlock will be joined by Dr. Charles (Chuck) Kettler, Director of Natoli Scientific, during the exposition portion of the meeting representing the partnership between the Natoli Institute and the Lachman Institute at Long Island University(LIU).
Be sure to join Mr. Sedlock and Dr. Kettler at Booth 1353!
During the meeting and exposition, students at LIU who work with both the Lachman and Natoli Institutes will present six posters on various topics relating to the tableting industry.
Click here to view the abstracts for these posters.
[image of LIU/Natoli Institute]
Natoli Institute for Industrial Pharmacy Research and Development and Lachman Institute for Pharmaceutical Analysis, located at Long Island University/Arnold & Marie Schwartz College of Pharmacy and Health Sciences in Brooklyn, NY, is dedicated to the support and advancement of pharmaceutical oral dosage formulation and engineering.